Higher-Dose Aricept Approved

7/27/2010

The FDA approved Eisai and Pfizer’s Aricept (donepezil hydrochloride) 23 mg tablets for the treatment of moderate to severe Alzheimer disease. The medication is also available in 5 and 10 mg tablets.

Clin-eguide™ is an online clinical decision support tool that provides the most accurate evidence-based information for health care providers in the clinical setting. It integrates trusted content from Ovid, Facts & Comparisons®, and Lippincott Williams and Wilkins, as well as other premier publishers.